Phenom Named Strategic Leader in Fosway 9-Grid™ for Talent Acquisition 2024 for Fourth Consecutive Year
30.5.2024 21:23:00 EEST | Business Wire | Press release
Phenom has been named a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition for the fourth consecutive year, demonstrating the comprehensive nature of its solution and its ability to innovate, drive business impact, and support with customer adoption and satisfaction compared to alternative talent acquisition software solutions. Fosway identifies Strategic Leaders as companies that provide a rich suite of capability across a broad scope of features and have the sophistication to consistently meet the needs of complex enterprise-scale customers. Strategic Leaders are also recognised by Fosway for having strong market performance and customer advocacy; as a result, they are frequently selected by such organisations and consistently meet their needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240530551981/en/
Phenom has been named a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition for the fourth consecutive year, demonstrating the comprehensive nature of its solution and its ability to innovate, drive business impact, and support with customer adoption and satisfaction compared to alternative talent acquisition software solutions. (Graphic: Business Wire)
The European job market is undergoing a significant transformation. Challenges such as talent shortages and technological disruptions are actively shaping the dynamics of recruitment practices. To navigate this, talent acquisition leaders, sourcers, talent marketers, recruitment events managers, and recruiters must adopt a multifaceted approach that encompasses building alliances, appropriately leveraging and consolidating technology, personalising candidate engagement, maximising utilisation of artificial intelligence and automation, and embracing data insights.
“The TA industry faces many challenges due to a fragmented tech stack, and companies often struggle to streamline their recruitment processes and engage candidates effectively,” said David Wilson, CEO and founder of Fosway Group. “Phenom’s Intelligent Talent Experience platform aims to deliver an effective, data-driven, personalised enterprise solution to these issues. Their continued innovation and customer outcomes are reflected in their position as a Strategic Leader for a fourth successive year.”
The Most Productive, Efficient Organisations Will Define the Decade Ahead
More than 600 global, diverse enterprises use Phenom’s automations, intelligence, and experience to achieve measurable, defensible results, including the ability to:
- Secure 5x more job seekers per month
- Increase chatbot-generated leads by 93%
- Improve application conversion with 85% completion rates
- Accelerate interview scheduling with 88% booked within 24 hours
- Cut 65 days off time to hire
- Save thousands of dollars per hire and reduce dependency on third-parties
“Phenom's fourth consecutive year being recognised as a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition reaffirms our commitment to innovation, customer impact, and advocacy,” said John Harrington, Senior Director, Product Marketing at Phenom. “Securing the highest positioning in performance and potential is a testament to our 13+ years in the industry and reflects our ability to partner with global organisations across all industries to address their unique challenges and exceed their goals.”
Leading the Way in Generative AI Adoption and Impact in HR
The advent of generative AI in the past year afforded Phenom a significant opportunity to address the challenges being experienced by its customers with immediate solutions that drive efficiency and productivity outcomes. Since its introduction in 2023, Phenom X+ Generative AI in Phenom’s Intelligent Talent Experience platform has been adopted by over 600 customers, supporting over 60 use cases, and saving HR teams 37,000 hours in the process. Top X+ generative AI use cases and examples of time savings include:
- Email generation, saving Talent CRM users over 6 minutes per email
- Generation of profile summaries, affording 15 hours back to talent acquisition teams each week
- Development of SMS and email campaigns, leading to 35% higher response rates from candidates
Unleashing a Massive Wave of HR Tech Innovation
Phenom continues to innovate by introducing new functionality and capabilities intended to address the top challenges being experienced by talent practitioners today.
2024 Phenom platform innovation highlights include:
- Talent Experience Engine: transforms talent marketers into strategists by leveraging large datasets to create personalised, on-brand campaigns. It enhances efficiency by unifying persona and journey data, enabling content creation, segment identification, personalised journeys, and automated outreach. This comprehensive set of tools optimises engagement and conversion for candidates, employees, and alumni.
- X+ Source: optimises sourcing by segmenting talent pools and creating personalised journeys to attract best-fit candidates. Simply request candidates for a specific role and location, and X+ Source finds the best-fit talent, provides recommendations, summarises key details, and conducts automatic outreach to establish initial contact.
- X+ Workforce Intelligence: connects data from employees, management, HR teams, candidates, and recruiters to provide real-time talent insights for proactive retention and growth. HR teams and managers can identify skills gaps, create personalised development plans, and designate successors based on data to find ideal candidates.
- Talent Marketer Experience: empowers talent marketers to craft personalised content, design campaigns, segment talent, and engage effectively using AI and automation. X+ Agents guide marketers through tasks, enhancing engagement throughout the talent lifecycle via a single, unified platform.
- Talent Leader Experience: provides recruitment managers with organisation-wide insights and individual performance data, including requisition and candidate interaction metrics. X+ Agents offer tailored action plans based on hiring type, enhancing team efficiency and effectiveness.
- X+ Screening: enables fast, intelligent hiring decisions by offering comprehensive insights based on recorded answers, situational judgment questions, and call simulations for all job types.
- Structured Interviews: streamlines interview processes with automated note-taking, question management, and real-time transcription. It enables hiring teams to focus on meaningful candidate interactions while reducing human error and leveraging AI for confident hiring decisions through organised and analysed data.
- Contingent Talent Hiring: helps top brands attract contractors effortlessly via Phenom. Companies can now seamlessly discover and hire temporary workers, with integrated support for Vendor Management Systems and payroll providers for smooth onboarding.
- Events Pro: streamlines event creation to easily target demographics through email, SMS, and registration forms. Personalised virtual event lobbies allow talent to review content, visit booths, and receive automatic event summaries via email.
- Phenom Assessments: have expanded the existing behavioral and language assessments to include motivation and interest assessments to guide early talent to the right jobs.
- X+ Fit Score: enables talent acquisition professionals to extend the typical criteria used to formulate fit scores, or customise the scores in the context of the role.
Companies across EMEA are successfully adopting Phenom’s Intelligent Talent Experience platform to help candidates find and choose the right job faster, employees develop their skills and evolve, recruiters become wildly productive, talent marketers engage with extreme efficiency, talent leaders optimise hiring processes, managers build stronger-performing teams, HR align employee development with company goals, and HRIS easily integrate existing HR tech to create a holistic infrastructure.
On June 6, Phenom is demonstrating its massive wave of recent platform innovations during its HR Innovation Showcase. Register here for the streaming event and see how Phenom continues to innovate, earning its position as a Strategic Leader for the fourth consecutive year.
About the Fosway 9-Grid™
Fosway Group is Europe’s #1 HR industry analyst. The Fosway 9-Grid™ provides a unique assessment of the principal learning and talent supply options available to organisations in EMEA. The analysis is based on extensive independent research and insights from Fosway’s Corporate Research Network of over 250 organisations, including BP, HSBC, PwC, RBS, Sanofi, Shell, and Vodafone. Visit the Fosway website at www.fosway.com.
About Phenom
Phenom has a purpose of helping a billion people find the right work. Through AI-powered talent experiences, employers use Phenom to hire employees faster, develop them to their full potential, and retain them longer. The Phenom Intelligent Talent Experience platform seamlessly connects candidates, employees, recruiters, talent marketers, talent leaders, hiring managers, HR and HRIS — empowering diverse and global enterprises with innovative products including Phenom X+ Generative AI, Career Site, Chatbot, CMS, Talent CRM, One-Way Interviews, Automated Interview Scheduling, Interview Intelligence, Talent Experience Engine, Campaigns, University Recruiting, Contingent Talent Hiring, Talent Marketplace, Workforce Intelligence, Career Pathing, Gigs, Mentoring, and Referrals.
Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (4 consecutive years), Deloitte Technology's Fast 500 (4 consecutive years), five Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in AI for Business Impact,’ Business Intelligence Group's Artificial Intelligence Excellence Awards (3 consecutive years), and a regional Timmy Award for launching and optimizing HelpOneBillion.com (2020).
Headquartered in Greater Philadelphia, Phenom also has offices in India, Israel, the Netherlands, Germany and the United Kingdom.
For more information, please visit www.phenom.com. Connect with Phenom on LinkedIn, Twitter, Facebook, YouTube and Instagram.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240530551981/en/
Contact information
Media:
Jennifer Lyons
Phenom
267-379-5066
jennifer.lyons@phenom.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Office of His Highness Sheikh Hamdan Bin Ahmed Al Maktoum Holdings & Gatbits IT Infrastructure Announce Launch of GTBS Digital Ecosystem; Mainnet Set for April 202630.3.2026 21:30:00 EEST | Press release
The Office of His Highness Sheikh Hamdan Bin Ahmed Al Maktoum Holdings, in collaboration with Gatbits IT Infrastructure, has officially announced the launch of the GTBS Digital Ecosystem, marking a significant step forward in the global Web3 space. The announcement follows the successful launch of the native GTBS Coin on December 25, with the ecosystem’s mainnet scheduled to go live in April 2026. GTBS represents a full-stack Web3 ecosystem integrating blockchain, artificial intelligence, decentralized finance (DeFi), entertainment, gaming, media, and cloud infrastructure into a unified platform. Built on the philosophy of “All Commitment On Time,” the ecosystem focuses on delivering reliability, scalability, and real-world utility. Designed as a comprehensive digital infrastructure, GTBS goes beyond standalone crypto platforms by offering an integrated environment for users, developers, creators, and enterprises. Its proprietary Layer-1 blockchain powers seamless interaction across se
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 16:00:00 EEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 15:00:00 EEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 15:00:00 EEST | Press release
The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 500 million AGR uranium pellets and 222,000 AGR grids – which is equivalent to burning over 685 tonnes of coal, avoiding the emission of nearly 3 billion tonnes of CO2. Sp
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano ® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 14:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
